A new contrast agent combination for imaging tumor samples enhances imaging and data extraction and thus benefits image-based modeling of tumor processes. The discovery will be presented today at the American Physiological Society (APS) Interface of Mathematical Models and Experimental Biology: Role of the Microvasculature Conference in Scottsdale, Ariz.
Click here for original story, New contrast agent combination could usher in a new era of vascular systems biology
Source: Phys.org